Indonesian Study Reveals Critical Gaps in Infective Endocarditis Treatment and Diagnosis

What Are the New Insights into Infective Endocarditis in Indonesia?

Indonesia's largest infective endocarditis study reveals significant mortality and treatment challenges in resource-limited settings, researchers at the National Cardiovascular Center Harapan Kita (NCCHK) Hospital report. The registry-based investigation of 376 patients with left-sided infective endocarditis (IE) found an 18.6% in-hospital mortality rate, with only 56.6% of patients receiving surgical intervention despite 76.1% meeting urgent surgical criteria.

The findings represent one of the first large-scale analyses of IE outcomes from a developing nation, addressing a critical knowledge gap in the global understanding of this life-threatening condition. While previous research from high-income countries has documented IE's evolving epidemiology and treatment challenges, the Indonesian study provides unique insights into disease manifestation and management in resource-constrained environments. Researchers identified several significant predictors of mortality, including advanced heart failure symptoms, aortic valve vegetation, large vegetation size (≥10 mm), incomplete antibiotic therapy, sepsis, and renal replacement therapy requirements. The study revealed that patients with urgent surgical indications who underwent valve surgery had significantly lower mortality (12.9%) compared to those who did not receive surgery (37.9%), underscoring the life-saving potential of timely intervention. However, investigators noted considerable logistical challenges in delivering surgical care within recommended timeframes, reflecting the practical realities of healthcare delivery in developing settings.

Are Diagnostic Limitations at the Heart of High BCNIE Rates?

The study also highlighted the substantial burden of blood culture-negative infective endocarditis (BCNIE), which accounted for 49.5% of cases—a proportion significantly higher than typically reported in developed nations. This finding reflects limitations in diagnostic capabilities rather than fundamental differences in disease etiology, according to the researchers. "The high BCNIE prevalence we observed highlights diagnostic challenges that are likely common across many resource-limited healthcare systems," noted study investigators. "While our mortality rates were comparable to international registries, the pathways to diagnosis and treatment differ substantially from high-income settings." The registry documented a diverse clinical presentation spectrum, with 66.8% of patients presenting with advanced heart failure symptoms (NYHA class III-IV), and 28.5% experiencing stroke events during hospitalization. Additional complications included sepsis (27.1%), prolonged ICU care (18.6%), and acute kidney injury requiring renal replacement therapy (15.4%).

Is Indonesia's IE Profile Different from Global Trends?

The findings align with previous international registry data in some respects while diverging in others. The 18.6% in-hospital mortality rate was lower than the 22.5% reported in the European EURO-ENDO registry but comparable to the 17.8-20.1% range documented in the International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS). However, the surgical intervention rate of 56.6% fell below the 65-73.9% reported in developed countries, highlighting resource and capacity constraints. The study also revealed differences in predisposing factors, with rheumatic and degenerative valvular heart disease predominating (91.5% of cases), while prosthetic valve endocarditis was less common (11.7%) than in high-income countries (up to 30%). Investigators noted that Streptococcus species were the most frequently identified pathogens among culture-positive cases, contrasting with the Staphylococcal predominance typically seen in Western registries.

What Are the Clinical Implications for Resource-Limited Settings?

The research team emphasized that their findings have significant implications for clinical practice and policy development in resource-constrained environments. The identification of specific mortality predictors could help clinicians prioritize high-risk patients for more intensive monitoring and earlier intervention. Additionally, the documented challenges in implementing guideline-recommended surgical timing suggest a need for context-specific protocols that acknowledge practical limitations while maximizing patient outcomes. Future research directions may include multi-center studies with longer follow-up periods and investigation into diagnostic enhancement strategies suitable for resource-limited settings. The team also highlighted the potential value of adapting international guidelines to accommodate the realities of healthcare delivery in developing countries, where advanced imaging modalities and optimal surgical timing may not always be feasible.

Which Factors Predict Adverse Outcomes in IE?

Multivariate analysis identified eight significant predictors for negative composite outcomes during hospitalization, including prolonged hospitalization exceeding 21 days, coagulase-negative Staphylococcus infection, acute renal failure, incomplete antibiotic administration, decreased right ventricular function, absence of surgical intervention, stroke events, and multiple surgical procedures. These findings provide valuable risk stratification tools for clinicians managing IE in similar settings. The study's comprehensive approach to documenting both mortality and morbidity outcomes offers a nuanced understanding of the disease burden beyond simple survival metrics.

How Can the Medical Industry Address These Challenges?

Industry Context: This study highlights a substantial market opportunity for pharmaceutical and medical device companies to develop diagnostic and therapeutic solutions tailored to resource-limited settings. The high prevalence of blood culture-negative IE suggests a particular need for affordable, accessible diagnostic alternatives to conventional culture methods. Additionally, the findings underscore the potential value of antibiotic regimens optimized for settings where surgical intervention may be delayed or unavailable. As global health equity gains prominence in industry priorities, this research provides valuable insights for companies seeking to address unmet needs in cardiovascular infectious diseases across diverse healthcare environments.

Summary

A landmark registry study from Indonesia's National Cardiovascular Center Harapan Kita Hospital examined 376 patients with left-sided infective endocarditis, revealing an 18.6% in-hospital mortality rate and significant treatment challenges in resource-limited settings. The research found that only 56.6% of patients received surgical intervention despite 76.1% meeting urgent surgical criteria, with mortality significantly lower among those who underwent surgery (12.9%) compared to those who did not (37.9%). The study documented a notably high rate of blood culture-negative infective endocarditis at 49.5%, substantially exceeding rates in developed nations and reflecting diagnostic limitations rather than disease differences. Key mortality predictors included advanced heart failure, aortic valve vegetation, large vegetation size, incomplete antibiotic therapy, sepsis, and renal replacement therapy requirements. The investigation revealed distinct epidemiological patterns compared to Western registries, with rheumatic and degenerative valvular disease predominating and Streptococcus species most commonly identified, contrasting with the Staphylococcal predominance typical in high-income countries. Additional complications were frequent, including stroke events in 28.5% of patients, sepsis in 27.1%, and acute kidney injury requiring dialysis in 15.4%. The findings underscore substantial healthcare delivery challenges in developing nations while highlighting opportunities for developing diagnostic and therapeutic solutions tailored to resource-constrained environments, particularly affordable alternatives to conventional blood culture methods and optimized antibiotic regimens for settings where timely surgical intervention may not be feasible.